Transplantation of myoblasts from a transgenic mouse overexpressing dystrophin produced only a relatively small increase of dystrophin-positive membrane

Muscle and Nerve

Volumn 21, Issue 1, 1998, Pages 91-103

  Kinoshita, I ^a   Vilquin, J T ^a   Asselin, I ^a   Chamberlain, J ^b   Tremblay, J P ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Dystrophin; Gene therapy; Myoblast transplantation; Nuclear domain; Transgenic mouse

Indexed keywords

DYSTROPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSPLANTATION; COMPUTER SIMULATION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; GENE THERAPY; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; BETA-GALACTOSIDASE; CELL TRANSPLANTATION; CELLS, CULTURED; COMPUTER SIMULATION; DNA PRIMERS; DNA, COMPLEMENTARY; DYSTROPHIN; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; NERVE FIBERS; POLYMERASE CHAIN REACTION; RECOMBINANT FUSION PROTEINS; REGRESSION ANALYSIS;

EID: 0031961756     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199801)21:1<91::AID-MUS12>3.0.CO;2-3     Document Type: Article

References (43)

1. Alameddine HS, Fardeau M: Regeneration of skeletal muscle induced by satellite cell grafts. Adv Exp Med Biol 1990;280:159-166.
2. Alameddine HS, Quantin B, Cartaud A, Dehaupas M, Mandel JL, Fardeau M: Expression of a recombinant dystrophin in mdx mice using adenovirus vector. Neuromusc Disord 1994;4:193-204.
3. Asselin I, Tremblay M, Vilquin JT, Guérette B, Tremblay JP: Quantification of normal dystrophin mRNA following myoblast transplantation in mdx mice. Muscle Nerve 1995;18:980-986.
4. Benoit PW, Belt WD: Destruction and regeneration of skeletal muscle after treatment with a local anaesthetic, bupivacaine (Marcaine). J Anat 1970;107:547-556.
5. Burghes AHM, Logan C, Hu X, Beifall B, Worton RG, Ray PN: A cDNA clone from the Duchenne Becker muscular dystrophy gene. Nature 1991;328:434-437.
6. Chomczynski P, Nicoletta S: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chlorophorm extraction. Anal Biochem 1987;162:156-159.
7. Cox GA, Cole NM, Matsumura K, Phelps SF, Hauschka SD, Campbell KP, Faulkner JA, Chamberlain JS: Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature 1993;364:725-729.
8. Guérette B, Asselin I, Vilquin JT, Roy R, Tremblay JP: Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice. Muscle Nerve 1995;18:39-51.
9. Guérette B, Roy R, Tremblay M, Asselin I, Kinoshita I, Tremblay JP: Increased granzyme B mRNA following alloincompatible myoblast transplantation. Transplantation 1995;60:1011-1016.
10. Gussoni E, Pavlath GK, Lanctot AM, Sharma K, Miller RG, Steinman L, Blau HM: Normal dystrophin transcripts detected in DMD patients after myoblast transplantation. Nature 1992;356:435-438.
11. Hallauer PL, Bradshaw HL, Hastings KEM: Complex fiber-type-specific expression of fast skeletal muscle troponin 1 gene constructs in transgenic mice. Development 1993;119:691-701.
12. Harris JB, Johnson MA, Karlsson E: Pathological responses of rat skeletal muscle to a single subcutaneous injection of a toxin isolated from the venom of the Australian tiger snake, Notechis scutatus scutatus. Clin Exp Pharmacol Physiol 1975;2:383-404.
13. Hoffman EP, Kunkel LM, Brown RH: Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987;51:919-928.
14. Huard J, Bouchard JP, Roy R, Malouin F, Dansereau G, Labrecque C, Albert N, Richards CL, Lemieux B, Tremblay JP: Human myoblast transplantation: preliminary results of four cases. Muscle Nerve 1992;15:550-560.
15. Huard J, Labrecque C, Dansereau G, Robitaille L, Tremblay JP: Dystrophin expression in myotubes formed by the fusion of normal and dystrophic myoblasts. Muscle Nerve 1991;14:178-182.
16. Huard J, Roy R, Guérette B, Verreault S, Tremblay G, Tremblay JP: Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection. Muscle Nerve 1994;17:224-234.
17. Huard J, Verreault S, Roy R, Tremblay M, Tremblay JP: High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J Clin Invest 1994;93:586-599.
18. Karpati G, Acsadi G: The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases. Muscle Nerve 1993;16:1141-1153.
19. Karpati G, Ajdukovic D, Arnold D, Glendhill RB, Guttmann R, Holland P, Koch PA, Shoubridge E, Spence D, Vanasse V, Watters GV, Abrahamowicz M, Duff C, Worton RG: Myoblast transfer in Duchenne muscular dystrophy. Ann Neurol 1993;34:8-17.
20. Karpati G, Pouliot Y, Zubrzycka-Gaarn E, Carpenter S, Ray PN, Worton RG, Holland P: Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. Am J Pathol 1989;135:27-32.
21. Karpati G, Zubrzycka-Gaarn EE, Carpenter S, Bulman D, Ray PR, Worton RG: Age-related conversion of dystrophin-negative to positive fiber segments of skeletal but not cardiac muscle fibers in heterozygote mdx mice. J Neuropathol Exp Neurol 1990;49:96-105.
22. Kinoshita I, Vilquin JT, Guérette B, Asselin I, Roy R, Tremblay JP: Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve 1994;17:1407-1415.
23. Kinoshita I, Vilquin JT, Tremblay JP: Pretreatment of myoblast cultures with basis fibroblast growth factor increases the efficacy of their transplantation in mdx mice. Muscle Nerve 1995;18:834-841.
24. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM: Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987;50:509-517.
25. Law PK, Bertorini TE, Goodwin TG, Chen M, Fang Q, Li H-J, Kirby DS, Florendo JA, Herrod HG, Golden GS: Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy. Lancet 1990;336:114-115.
26. Law PK, Goodwin TG, Fang Q, Deering MD, Duggirala V, Larkin C, Florendo JA, Kirby DS, Li HJ, Chen M, Cornett J, Li LM, Shirzad A, Quinley T, Yoo TJ, Holcomb R: Cell transplantation as an experimental treatment for Duchenne muscular dystrophy. Cell Transplantation 1993;2:485-505.
27. Law PK, Goodwin TG, Wang MG: Normal myoblast injections provide genetic treatment for murine dystrophy. Muscle Nerve 1988;11:525-533.
28. Lee CC, Pearlman JA, Chamberlain JS, Caskey CT: Expression of recombinant dystrophin and its localization to the cell membrane. Nature 1991;349:334-336.
29. Morgan JE, Partridge TA: Cell transplantation and gene therapy in muscular dystrophy. BioEssays 1992;14:641-645.
30. Partridge TA, Morgan JE, Coulton GR, Hoffmann EP, Kunkel LM: Conversion of mdx myofibres from dystrophin-negative to positive by injection of normal myoblasts. Nature 1989;337:176-179.
31. Pavlath GK, Rich K, Webster SG, Blau HM: Localization of muscle gene products in nuclear domains. Nature 1989;337:570-573.
32. Pegoraro E, Schimke RN, Garcia C, Stern H, Cadaldini M, Angelini C, Barbosa E, Carroll J, Marks WA, Neville HE, Marks H, Appleton S, Toriello H, Wessel HB, Donnelly J, Bernes SM, Taber JW, Weiss L, Hoffman EP: Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: evidence for failure of dystrophin production in dystrophin-competent myonuclei. Neurology 1995;45:677-690.
33. Rafael JA, Sunada Y, Cole NM, Campbell KP, Faulkner JA, Chamberlain JS: Prevention of dystrophic pathology in mdx mice by a truncated dystrophin isoform. Hum Mol Genet 1994;3:1725-1733.
34. Ragot T, Vincent NP, Chafey E, Vigne H, Gilgenkrantz D, Couton J, Cartaud P, Briand JC, Kaplan Perricaudet M, Kahn A: Efficient adenovirus-mediated transfer of a human mini-dystrophin gene to skeletal muscle of mdx mice. Nature 1993;361:647-650.
35. Rando TA, Blau HM: Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol 1994;125:1275-1287.
36. Schrager JB, Naji A, Kelly AM, Stedman HH: A PCR-based assay for the wild-type dystrophin gene transferred into mdx mouse. Muscle Nerve 1992;15:1133-1137.
37. Sharp NJH, Kornegay JN, Bartlett RJ, Hung WY, Dykstra MJ: Notexin-induced muscle injury in the dog. J Neurol Sci 1993;116:73-81.
38. Sicinsky P, Geng Y, Ryder-Cook AS, Barnard EA, Darkinson MG, Barnard PJ: The molecular bases of muscular dystrophy in the mdx mouse: a point mutation. Science 1989;244:1578-1580.
39. Tinoco I Jr, Sauer K, Wang JC: Physical Chemistry. Principles and Applications in Biological. Sciences. Englewood Cliffs, NJ, Prentice-Hall, 1985.
40. Tremblay JP, Malouin F, Roy R, Huard J, Bouchard JP, Satoh A, Richards CL: Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplantation 1993;2:99-112.
41. Vilquin JT, Wagner E, Kinoshita I, Roy R, Tremblay JP: Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin. J Cell Biol 1995;131:975-988.
42. Watkins SC, Hoffman EP, Slayter HS, Kunkel LM: Dystrophin distribution in heterozygote mdx mice. Muscle Nerve 1989;12:1066-1069.
43. Watt DJ, Partridge TA, Sloper JG: Cyclosporin as a means of preventing rejection of skeletal muscle allografts in mice. Transplantation 1981;31:266-271.